These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 20001209)

  • 1. The NF-kappaB activation pathways, emerging molecular targets for cancer prevention and therapy.
    Lin Y; Bai L; Chen W; Xu S
    Expert Opin Ther Targets; 2010 Jan; 14(1):45-55. PubMed ID: 20001209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NF-kappaB in lung cancer, a carcinogenesis mediator and a prevention and therapy target.
    Chen W; Li Z; Bai L; Lin Y
    Front Biosci (Landmark Ed); 2011 Jan; 16(3):1172-85. PubMed ID: 21196225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NF-kappaB, inflammation and pancreatic carcinogenesis: NF-kappaB as a chemoprevention target (review).
    Zhang Z; Rigas B
    Int J Oncol; 2006 Jul; 29(1):185-92. PubMed ID: 16773199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NF-κB Signaling Pathway Inhibitors as Anticancer Drug Candidates.
    de Castro Barbosa ML; da Conceicao RA; Fraga AGM; Camarinha BD; de Carvalho Silva GC; Lima AGF; Cardoso EA; de Oliveira Freitas Lione V
    Anticancer Agents Med Chem; 2017; 17(4):483-490. PubMed ID: 27481554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear factor-kappa B and cancer: its role in prevention and therapy.
    Bharti AC; Aggarwal BB
    Biochem Pharmacol; 2002 Sep; 64(5-6):883-8. PubMed ID: 12213582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting NF-kappaB for colorectal cancer.
    Sakamoto K; Maeda S
    Expert Opin Ther Targets; 2010 Jun; 14(6):593-601. PubMed ID: 20367537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibiting NF-κB activation by small molecules as a therapeutic strategy.
    Gupta SC; Sundaram C; Reuter S; Aggarwal BB
    Biochim Biophys Acta; 2010; 1799(10-12):775-87. PubMed ID: 20493977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NF-kappaB as a potential molecular target for cancer therapy.
    Lee CH; Jeon YT; Kim SH; Song YS
    Biofactors; 2007; 29(1):19-35. PubMed ID: 17611291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NF-kappa B signaling and carcinogenesis.
    Okamoto T; Sanda T; Asamitsu K
    Curr Pharm Des; 2007; 13(5):447-62. PubMed ID: 17348842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IKK/NF-kappaB and STAT3 pathways: central signalling hubs in inflammation-mediated tumour promotion and metastasis.
    Bollrath J; Greten FR
    EMBO Rep; 2009 Dec; 10(12):1314-9. PubMed ID: 19893576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear factor-kappaB: the enemy within.
    Aggarwal BB
    Cancer Cell; 2004 Sep; 6(3):203-8. PubMed ID: 15380510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression.
    Bassères DS; Baldwin AS
    Oncogene; 2006 Oct; 25(51):6817-30. PubMed ID: 17072330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NF-κB in cancer therapy.
    Li F; Zhang J; Arfuso F; Chinnathambi A; Zayed ME; Alharbi SA; Kumar AP; Ahn KS; Sethi G
    Arch Toxicol; 2015 May; 89(5):711-31. PubMed ID: 25690730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NF-kappaB as a therapeutic target in cancer.
    Orlowski RZ; Baldwin AS
    Trends Mol Med; 2002 Aug; 8(8):385-9. PubMed ID: 12127724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a novel blocker of I kappa B alpha kinase that enhances cellular apoptosis and inhibits cellular invasion through suppression of NF-kappa B-regulated gene products.
    Ichikawa H; Takada Y; Murakami A; Aggarwal BB
    J Immunol; 2005 Jun; 174(11):7383-92. PubMed ID: 15905586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of NF-κB and NF-κB-Regulated Gene Expression by Apigenin through IκBα and IKK Pathway in TRAMP Mice.
    Shukla S; Shankar E; Fu P; MacLennan GT; Gupta S
    PLoS One; 2015; 10(9):e0138710. PubMed ID: 26379052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NF-kappaB and rheumatic diseases.
    Okamoto T
    Endocr Metab Immune Disord Drug Targets; 2006 Dec; 6(4):359-72. PubMed ID: 17214582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation and cancer: when NF-kappaB amalgamates the perilous partnership.
    Dobrovolskaia MA; Kozlov SV
    Curr Cancer Drug Targets; 2005 Aug; 5(5):325-44. PubMed ID: 16101381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear factor-kappaB activation: from bench to bedside.
    Sethi G; Sung B; Aggarwal BB
    Exp Biol Med (Maywood); 2008 Jan; 233(1):21-31. PubMed ID: 18156302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indirubin enhances tumor necrosis factor-induced apoptosis through modulation of nuclear factor-kappa B signaling pathway.
    Sethi G; Ahn KS; Sandur SK; Lin X; Chaturvedi MM; Aggarwal BB
    J Biol Chem; 2006 Aug; 281(33):23425-35. PubMed ID: 16785236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.